ExeVir Bio Overview
Company Headquarters: Ghent, Belgium
Founded: 2020
Workforce: ~10
Company Working: ExeVir Bio is a clinical-stage company that is developing novel antibody therapies that are used in the treatment of infectious diseases. The company is utilizing highly innovative and clinically supported VHH technology to develop a treatment for viral infections. ExeVir cooperates closely with Belgium’s leading life sciences research institute VIB, developing new VHH antibodies together with the laboratories. The company has a strong distribution network in the Asia-Pacific region.
Strategy
ExeVir Bio BV. focuses on the development of high-quality products to meet customer demand across the globe. The company emphasizes expanding research and development capability to develop products as well as continue to improve customer outcomes. It also aims at extending its distribution network in the region to increase its market share and revenue.



